MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
UPDATE: MiMedx Group (MDXG) Reports Q3 EPS of $0.08, Offers Q4 Guidance
October 26, 2017 2:01 PM EDT(Updated - October 26, 2017 2:04 PM EDT)
MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.08, versus $0.06 reported last year. Revenue for the quarter came in at $84.6 million, versus $64.43 million reported last year.
Fourth Quarter and Full Year 2017 Guidance HighlightsMiMedx provided its revenue... More
